Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity

被引:218
作者
Zhang, Xiao-Yu [1 ]
Chen, Jiang [1 ,2 ,3 ]
Yi, Kang [1 ]
Peng, Ling [1 ]
Xie, Jie [1 ]
Gou, Xun [1 ]
Peng, Tong [4 ]
Tang, Lin [2 ]
机构
[1] Sichuan Normal Univ, Coll Life Sci, Chengdu 610101, Peoples R China
[2] Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China
[3] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China
[4] Keystonecare Technol Chengdu Co Ltd, R&D Dept, Chengdu, Peoples R China
关键词
Phlorizin (PHZ); obesity; gut microbiota; short-chain fatty acids (SCFAs); glucagon-like peptide 2 (GLP-2); barrier integrity;
D O I
10.1080/19490976.2020.1842990
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Phlorizin (PHZ) is one of phytonutrients in apples that contributes to the health-promoting effect implicated by the saying, 'an apple a day keeps the doctor away'. PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms. This study aimed to investigate the ameliorating effect of PHZ on high-fat diet (HFD)-induced obesity via modulating the "gut microbiota-barrier axis". Firstly, C57BL/6 J mice were fed a normal chow diet (NCD) or HFD coadministered with or without PHZ for 12 weeks. Our results showed that PHZ supplementation significantly reduced HFD-induced body weight gain (P .001), alleviated metabolic disorders (MDs) like insulin resistance (P .001) and elevation of serum lipopolysaccharides (LPS) (P .001), attenuated HFD-induced gut microbiota alterations, enhanced short-chain fatty acids (SCFAs) production (P .001), and inhibited fecal LPS production (P .001). To investigate the role of the fecal microbiota in the observed beneficial effects, a fecal microbiota transplantation (FMT) experiment was performed by transplanting the feces of the four groups of mice (as donor mice) daily collected from the fourth week to a new batch of acclimatized HFD-fed mice. Our results confirmed that feeding the gut contents of the PHZ-modulated mice could attenuate HFD-induced MDs, accompanied by enhanced glucagon-like peptide 2 (GLP-2) secretion (P .001) and restoration of HFD-induced damage in the gut epithelial barrier. This study has provided evidence that the "gut microbiota-barrier axis" was an alternative target for the anti-obesity effect of PHZ. This work has also provided an explanation for the high efficacy of PHZ despite the low bioavailability, and PHZ holds great potential to be developed as a functional food ingredient.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 61 条
[1]   Faecal quality control [J].
不详 .
NATURE MICROBIOLOGY, 2019, 4 (08) :1243-1243
[2]  
Arnolds Kathleen L., 2016, Yale Journal of Biology and Medicine, V89, P389
[3]   Optimization of microwave-assisted extraction of polyphenols from apple pomace using response surface methodology and HPLC analysis [J].
Bai, Xue-Lian ;
Yue, Tian-Li ;
Yuan, Ya-Hong ;
Zhang, Hua-Wei .
JOURNAL OF SEPARATION SCIENCE, 2010, 33 (23-24) :3751-3758
[4]   Biochemical and antimicrobial activity of phloretin and its glycosilated derivatives present in apple and kumquat [J].
Barreca, Davide ;
Bellocco, Ersilia ;
Lagana, Giuseppina ;
Ginestra, Giovanna ;
Bisignano, Carlo .
FOOD CHEMISTRY, 2014, 160 :292-297
[5]   The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities [J].
Brunkwall, Louise ;
Orho-Melander, Marju .
DIABETOLOGIA, 2017, 60 (06) :943-951
[6]   Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice [J].
Cani, Patrice D. ;
Bibiloni, Rodrigo ;
Knauf, Claude ;
Neyrinck, Audrey M. ;
Neyrinck, Audrey M. ;
Delzenne, Nathalle M. ;
Burcelin, Remy .
DIABETES, 2008, 57 (06) :1470-1481
[7]   Metabolic endotoxemia initiates obesity and insulin resistance [J].
Cani, Patrice D. ;
Amar, Jacques ;
Iglesias, Miguel Angel ;
Poggi, Marjorie ;
Knauf, Claude ;
Bastelica, Delphine ;
Neyrinck, Audrey M. ;
Fava, Francesca ;
Tuohy, Kieran M. ;
Chabo, Chantal ;
Waget, Aurelie ;
Delmee, Evelyne ;
Cousin, Beatrice ;
Sulpice, Thierry ;
Chamontin, Bernard ;
Ferrieres, Jean ;
Tanti, Jean-Francois ;
Gibson, Glenn R. ;
Casteilla, Louis ;
Delzenne, Nathalie M. ;
Alessi, Marie Christine ;
Burcelin, Remy .
DIABETES, 2007, 56 (07) :1761-1772
[8]   Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer [J].
Cani, Patrice D. ;
Jordan, Benedicte F. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (11) :671-682
[9]   The gut microbiota: A key factor in the therapeutic effects of (poly) phenols [J].
Carlos Espin, Juan ;
Gonzalez-Sarrias, Antonio ;
Tomas-Barberan, Francisco A. .
BIOCHEMICAL PHARMACOLOGY, 2017, 139 :82-93
[10]   SGLT2 inhibition - a novel strategy for diabetes treatment [J].
Chao, Edward C. ;
Henry, Robert R. .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (07) :551-559